BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3481540)

  • 1. [Action of the antitumor antibiotic aclarubicin on the blood system and bone marrow hematopoiesis in an experiment].
    Svinogeeva TP
    Antibiot Med Biotekhnol; 1987 Dec; 32(12):915-9. PubMed ID: 3481540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Action of reumycin on the blood system in an experiment].
    Svinogeeva TP; Berezina EK; Raĭko LI
    Antibiotiki; 1984 Jul; 29(7):516-9. PubMed ID: 6486750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of aclacinomycin A on bone marrow (author's transl)].
    Ohmori K; Shirai M; Kiyosaki T; Hori S; Tone H
    Jpn J Antibiot; 1980 Apr; 33(4):436-52. PubMed ID: 6931916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetic study of aclarubicin. The pharmacokinetics of the preparation and its biologically active metabolites in the blood of rats].
    Geodakian SV; Firsov AA; Fomina IP
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):768-72. PubMed ID: 3480699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Myelotoxic action of the new antitumor preparation spirobramin].
    Gol'dberg ED; Novitskiĭ VV; Chernov VA; Dalinger LM; Plotnikov VM
    Farmakol Toksikol; 1983; 46(3):84-8. PubMed ID: 6861995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)].
    Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP
    Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of rubomycin C on the blood system in experimental conditions].
    Gol'dberg DI; Kraìushkina NP; Antipov IG
    Antibiotiki; 1971 Mar; 16(3):240-3. PubMed ID: 5558685
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the effect of reumycin on hemopoiesis normal animals and in some forms of experimental leukosis].
    Khanykova OK; Koropov IV
    Antibiotiki; 1968 Jun; 13(6):501-5. PubMed ID: 5678105
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetic study of aclarubicin. The distribution of the preparation and its biologically active metabolites in rat tissues].
    Firsov AA; Geodakian SV; Egorov LV; Terent'eva TG
    Antibiot Med Biotekhnol; 1987 Oct; 32(10):773-7. PubMed ID: 3480700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of the purified antibiotic neocid on the peripheral blood of laboratory animals].
    Derkach EM
    Antibiotiki; 1970 Mar; 15(3):274-6. PubMed ID: 5447130
    [No Abstract]   [Full Text] [Related]  

  • 11. [Reactivity of the blood system in the late periods following administration of the antitumor antibiotic rubomycin].
    Novitskiĭ VV; Fursov SE; Gol'dberg ED
    Biull Eksp Biol Med; 1985 Dec; 100(12):718-9. PubMed ID: 4074877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute toxicity of aclacinomycin A in mice, rats and dogs (author's transl)].
    Shirai M; Ohmori K; Hirano S; Iguchi H; Hori S; Sato H
    Jpn J Antibiot; 1980 Feb; 33(2):138-49. PubMed ID: 6929357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Late effects of the hematotoxic action of antineoplastic antibiotics of the anthracycline group].
    Gol'dberg ED; Novitskiĭ VV; Fursov SE
    Antibiot Khimioter; 1988 Sep; 33(9):671-6. PubMed ID: 3218991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Myeloinhibitory effect of the action of some antitumor antibiotics and its comparative assessment].
    Antipov IG; Novitskiĭ VV; Gol'dberg ED
    Antibiotiki; 1975 Oct; 20(10):897-902. PubMed ID: 1211886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Reactions of the blood system during experimental administration of the antineoplastic antibiotic bruneomycin].
    Gol'dberg DI; Karpova GV
    Antibiotiki; 1969 Sep; 14(9):845-9. PubMed ID: 5361830
    [No Abstract]   [Full Text] [Related]  

  • 16. [Aclacinomycin A: a new antitumor antibiotic].
    Egorov LV; Ivanitskaia LP; Navashin SM
    Antibiotiki; 1982; 27(7):540-55. PubMed ID: 6753735
    [No Abstract]   [Full Text] [Related]  

  • 17. [Subacute toxicity of aclacinomycin A in rats (author's transl)].
    Shirai M; Ohmori K; Hirano S; Iguchi H; Hori S; Sato H
    Jpn J Antibiot; 1980 Feb; 33(2):151-62. PubMed ID: 6929358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The stimulating effect of sialic acid on the processes of postradiation hemopoietic regeneration].
    Agafonov VI; Dygaĭ AM; Boldyshev DA; Khlusov IA; Gol'dberg ED
    Eksp Klin Farmakol; 1995; 58(4):41-4. PubMed ID: 7580752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hematopoietic study of rats in experiments with exchange blood replacement by an emulsion of perfluorotributylamine].
    Gusenova FM; Konovalova NV; Ivanova NL; Aprosin IuD; Sidliarov DP
    Biull Eksp Biol Med; 1979 Jun; 87(6):531-3. PubMed ID: 465682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of the myelotoxic action of rubomycin, adriamycin and carminomycin by their delayed effects in an experiment].
    Fursov SE; Novitskiĭ VV; Fedorenko EN; Gol'dberg ED
    Antibiot Med Biotekhnol; 1985 Apr; 30(4):284-8. PubMed ID: 4026249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.